missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Tyrosinase Monoclonal Antibody (T311)
Mouse Monoclonal Antibody
Marca: Invitrogen™ MA514177
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
MA5-14177 targets Tyrosinase in ICC, IF, IHC (P), and WB applications and shows reactivity with Human samples. The MA5-14177 immunogen is recombinant tyrosinase protein.
The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene.
Especificaciones
| Tyrosinase | |
| Monoclonal | |
| 0.2 mg/mL | |
| PBS with 0.05% BSA and 0.05% sodium azide; pH 7.4 | |
| P11344, P14679 | |
| TYR | |
| Recombinant tyrosinase protein. | |
| 500 μL | |
| Primary | |
| Human, Mouse | |
| Antibody | |
| IgG2a κ |
| Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| T311 | |
| Unconjugated | |
| TYR | |
| albino; albino locus protein; ATN; C; CMM8; LB24-AB; monophenol monooxygenase; Oca1; OCA1A; OCAIA; oculocutaneous albinism IA; SHEP3; SK29-AB; skc35; Tumor rejection antigen AB; TYR; Tyrosinase; tyrosinase (oculocutaneous albinism IA); tyrosinase precursor | |
| Mouse | |
| Protein A/G | |
| RUO | |
| 22173, 7299 | |
| 4°C | |
| Liquid |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido